Clozapine-Induced Neuroleptic Malignant Syndrome and Subdural Hematoma [3]

Journal of Neuropsychiatry and Clinical Neurosciences

Volumn 16, Issue 1, 2004, Pages 118-119

  Duggal, Harpreet S ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORPROMAZINE; CLOZAPINE; LITHIUM; LORAZEPAM; LOXAPINE; NIFEDIPINE; VALPROIC ACID;

ADULT; BIPOLAR DISORDER; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; FLUID THERAPY; HUMAN; HYPERTENSION; LETTER; MALE; NEUROLEPTIC MALIGNANT SYNDROME; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; SUBDURAL HEMATOMA; TREATMENT OUTCOME;

EID: 1242307400     PISSN: 08950172     EISSN: None     Source Type: Journal    
DOI: 10.1176/jnp.16.1.118     Document Type: Letter

References (7)

1. Caroff SN, Mann SC, Campbell EC. Atypical antipsychotics and neuroleptic malignant syndrome. Psychiatric Annals 2000; 30:314-321
2. Lazarus A. Neuroleptic malignant syndrome and preexisting brain damage. J Neuropsychiatry Clin Neurosci 1992; 4:185-187
3. Stockman M, Olson J, Gorbien M. Neuroleptic malignant syndrome with clozapine use in pre-senilin-1 Alzheimer's disease. J Am Geriatr Soc 2001; 49:S89-S90
4. Wilkinson R, Meythaler JM, Guin-Renfroe S. Neuroleptic malignant syndrome induced by haloperidol following traumatic brain injury. Brain Inj 1999; 13:1025-1031
5. Kmieciak-Kolada K, Felinska W, Stachura Z, Majchrzak H, Herman ZS. Concentration of biogenic amines and their metabolites in different parts of brain after experimental cerebral concussions. Pol J Pharmacol Pharm 1987; 39:47-53
6. Carroll BT. The universal field hypothesis of catatonia and neuroleptic malignant syndrome. CNS Spectrums 2000; 5:26-33
7. Heinemann F, Assion HJ, Hermes G, Ehrlich M. Paroxetine-induced neuroleptic malignant syndrome. Nervenarzt 1997; 68:664-666.